582 studies found for:    i-crest
Show Display Options
Rank Status Study
1 Withdrawn Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors
Conditions: Metastatic Non-Small Cell Lung Cancer;   Metastatic Colon Cancer;   Metastatic Triple Negative Breast Cancer
Interventions: Drug: CTLA-4 Antibody;   Radiation: Hypofractionated Radiotherapy
2 Completed
Has Results
Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women
Condition: Osteoporosis, Post-menopausal
Interventions: Drug: Teriparatide;   Drug: Zoledronic Acid
3 Completed A Comparison of Bupivacaine and Ketorolac for Postoperative Analgesia After Iliac Crest Bone Harvesting
Condition: Postoperative Pain
Interventions: Drug: Ketorolac;   Drug: Bupivacaine;   Drug: ketorolac + bupivacaine
4 Recruiting Safety Study of Mesenchymal Stem Cells and Spinal Fusion
Conditions: Lumbar Spondylolisthesis Involving L4-L5, and/or;   Degenerative Discopathy Involving L4-L5
Interventions: Biological: XCEL-MT-OSTEO-ALPHA;   Procedure: Standard treatment
5 Active, not recruiting Bilateral Sinus Floor Augmentation in Conjunction With Immediate Implant Loading - Study on 3i Dental Implants
Condition: Mouth, Edentulous
Intervention: Procedure: Bilateral sinus augmentation with immediately loaded dental implants
6 Active, not recruiting Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Dietary Supplement: selenium;   Other: placebo
7 Completed Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
Condition: Osteoporosis
Interventions: Drug: Teriparatide;   Drug: Denosumab;   Drug: Demeclocyline;   Drug: Tetracycline;   Drug: Calcium Supplement;   Drug: Vitamin D
8 Completed I-123-MIBG for Imaging of Neuroblastoma and Pheochromocytoma
Conditions: Neuroblastoma;   Pheochromocytoma
Intervention:
9 Recruiting Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Conditions: Adult Acute Megakaryoblastic Leukemia (M7);   Adult Acute Minimally Differentiated Myeloid Leukemia (M0);   Adult Acute Monoblastic Leukemia (M5a);   Adult Acute Monocytic Leukemia (M5b);   Adult Acute Myeloblastic Leukemia With Maturation (M2);   Adult Acute Myeloblastic Leukemia Without Maturation (M1);   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Adult Acute Myelomonocytic Leukemia (M4);   Adult Erythroleukemia (M6a);   Adult Pure Erythroid Leukemia (M6b);   Childhood Acute Erythroleukemia (M6);   Childhood Acute Megakaryocytic Leukemia (M7);   Childhood Acute Monoblastic Leukemia (M5a);   Childhood Acute Monocytic Leukemia (M5b);   Childhood Acute Myeloblastic Leukemia With Maturation (M2);   Childhood Acute Myeloblastic Leukemia Without Maturation (M1);   Childhood Acute Myelomonocytic Leukemia (M4);   Untreated Adult Acute Myeloid Leukemia;   Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
Interventions: Drug: asparaginase;   Drug: daunorubicin hydrochloride;   Drug: mitoxantrone hydrochloride;   Drug: sorafenib tosylate;   Drug: cytarabine;   Drug: etoposide;   Drug: bortezomib;   Other: pharmacological study;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Other: quality-of-life assessment
10 Not yet recruiting Ridge Preservation With New Class of Osteoplastic Materials
Conditions: Tooth Extraction;   Atrophy of Edentulous Alveolar Ridge
Interventions: Device: Octacalcium phosphate;   Device: Bio-Oss;   Device: Tricalcium phosphate
11 Recruiting Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IA Cervical Cancer;   Stage IB Cervical Cancer;   Stage IIA Cervical Cancer
Interventions: Drug: cisplatin;   Radiation: external beam radiation therapy;   Radiation: intensity-modulated radiation therapy;   Other: quality-of-life assessment;   Other: laboratory biomarker analysis
12 Recruiting Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer
Conditions: Childhood Hepatoblastoma;   Stage I Childhood Liver Cancer;   Stage II Childhood Liver Cancer;   Stage III Childhood Liver Cancer;   Stage IV Childhood Liver Cancer
Interventions: Procedure: therapeutic conventional surgery;   Drug: cisplatin;   Drug: fluorouracil;   Drug: vincristine sulfate;   Drug: doxorubicin hydrochloride;   Drug: irinotecan hydrochloride;   Drug: temsirolimus;   Procedure: liver transplantation;   Other: laboratory biomarker analysis
13 Not yet recruiting Mesenchymal Stromal Cells for the Treatment of Non-union Fractures of Long Bones
Condition: Atrophic Nonunion of Fracture
Interventions: Drug: XCEL-MT-OSTEO-ALPHA;   Other: autologous iliac crest;   Procedure: Surgery
14 Active, not recruiting Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritorium Cavity Cancer
Conditions: Ovarian Carcinosarcoma;   Recurrent Ovarian Epithelial Cancer;   Recurrent Primary Peritoneal Cavity Cancer;   Recurrent Uterine Sarcoma;   Stage I Uterine Sarcoma;   Stage IA Ovarian Epithelial Cancer;   Stage IA Primary Peritoneal Cavity Cancer;   Stage IB Ovarian Epithelial Cancer;   Stage IB Primary Peritoneal Cavity Cancer;   Stage IC Ovarian Epithelial Cancer;   Stage IC Primary Peritoneal Cavity Cancer;   Stage II Uterine Sarcoma;   Stage IIA Ovarian Epithelial Cancer;   Stage IIA Primary Peritoneal Cavity Cancer;   Stage IIB Ovarian Epithelial Cancer;   Stage IIB Primary Peritoneal Cavity Cancer;   Stage IIC Ovarian Epithelial Cancer;   Stage IIC Primary Peritoneal Cavity Cancer;   Stage III Uterine Sarcoma;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Primary Peritoneal Cavity Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Primary Peritoneal Cavity Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Primary Peritoneal Cavity Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Primary Peritoneal Cavity Cancer;   Stage IV Uterine Sarcoma;   Uterine Carcinosarcoma
Interventions: Drug: paclitaxel;   Drug: carboplatin;   Drug: ifosfamide
15 Active, not recruiting Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Condition: Breast Cancer
Interventions: Radiation: 3-dimensional conformal accelerated partial breast irradiation;   Radiation: brachytherapy;   Radiation: whole breast irradiation;   Radiation: MammoSite or other single-entry intracavitary device
16 Active, not recruiting Sequential Chemo-Radioimmunotherapy Followed by Autologous Transplantation for Patients With Untreated Advanced Stage Mantle Cell Lymphoma
Condition: Mantle Cell Lymphoma
Intervention: Other: R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.
17 Active, not recruiting Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Biological: bevacizumab;   Drug: dasatinib;   Other: placebo
18 Active, not recruiting Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
Conditions: Adult Anaplastic Astrocytoma;   Adult Anaplastic Oligodendroglioma;   Adult Diffuse Astrocytoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Mixed Glioma;   Adult Oligodendroglioma;   Recurrent Adult Brain Tumor
Interventions: Drug: temsirolimus;   Drug: perifosine;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis
19 Active, not recruiting Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
Conditions: Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Stage I Endometrial Carcinoma;   Stage II Endometrial Carcinoma;   Stage III Endometrial Carcinoma;   Stage IV Endometrial Carcinoma
Interventions: Drug: cisplatin;   Drug: paclitaxel;   Drug: carboplatin;   Radiation: brachytherapy
20 Completed Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model
Condition: Breast Cancer
Intervention: Drug: Capecitabine and Bevacizumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years